Sandoglobulin: transfer patients to liquid formulation as soon as possible

Patients currently being treated with Sandoglobulin (human normal immunoglobulin) powder for solution for infusion should be transferred to Sandoglobulin NF Liquid (solution for infusion) as soon as is practically possible.

Sandoglobulin NF Liquid is available as a 12% solution in 6g/50ml and 12g/100ml presentations at a cost of £186.36 and £372.72, respectively.

In addition to being more convenient than the powdered formulation, the liquid offers improved safety by virtue of its three-stage pathogen inactivation process during manufacture, low IgA levels and being free from carbohydrate stabilisers.

Sandoglobulin powder for solution for infusion 1g, 6g and 12g has been discontinued.

Further information: ZLB Behring Ltd, Hayworth House, Market Place, Haywards Heath, West Sussex RH16 1DB. Tel: (01444) 447400.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases